Lisa Jenkins Chairs DIA Event: Discuss FDA Initiatives

Our own Lisa Jenkins, PhD will chair the event

Discuss FDA Initiatives and Strategies for
Better Communication

presented by the DIA this week, June 24, 11:00AM – 12:30PM, ET, Online.

The passage of the FDA Safety and Innovation Act (FDASIA) holds the promise of a new era of open dialog and communication with FDA. FDA and industry experts will discuss the current FDA initiatives that support open dialog and communication between FDA and stakeholders; summarize the key findings from an independent assessment of the Program obtained by Eastern Research Group, Inc. (ERC); and provide specific FDA and industry perspectives on the Program and CPIM successes and limitations.

Register for this event.


  • Lisa Jenkins, PhD, Vice President, Regulatory Strategy and Content Development
    Virtual Regulatory Solutions, Inc.
  • Alexis Reisin Miller, JD, Senior Director, Regulatory Policy and Intelligence, Eisai Inc.
  • James Kaiser, MD, Medical and Scientific Lead, Critical Path Innovation Meetings, FDA